Literature DB >> 9877444

A novel sensitive and selective bioassay for human type I interferons.

J G Files1, J L Gray, L T Do, W P Foley, J D Gabe, E Nestaas, E Pungor.   

Abstract

We describe a novel MxA gene-induction assay for type I interferons (IFN-alpha and IFN-beta) based on the specific induction of the MxA gene in cultured human cells. Accumulated intracellular MxA protein is determined by immunologic measurement by a rapid method using commercially available materials. IFN activity can be measured accurately over a concentration range of 0.1-30 IU/ml. In contrast, type II IFN and other cytokines are not significantly detected. The MxA-induction assay has advantages in terms of specificity, reliability, and sensitivity over other methods for assaying type I IFN. It has also been adapted and validated for measuring the titers of anti-IFN-beta neutralizing antibodies in human sera.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877444     DOI: 10.1089/jir.1998.18.1019

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

1.  The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.

Authors:  Luca Durelli; Pierangelo Barbero; Mauro Bergui; Elisabetta Versino; Marco A Bassano; Elisabetta Verdun; Bruno Ferrero; Chiara Rivoiro; Cinzia Ferrero; Elisabetta Picco; Paolo Ripellino; Daniela Viglietti; Giorgio Giuliani; Enrico Montanari; Marinella Clerico
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

2.  In vitro and in vivo detection of Mx gene products in bovine cells following stimulation with alpha/beta interferon and viruses.

Authors:  Doris Müller-Doblies; Mathias Ackermann; Alfred Metzler
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Strategies to Determine Assay Format for the Assessment of Neutralizing Antibody Responses to Biotherapeutics.

Authors:  Bonnie Wu; Shan Chung; Xu-Rong Jiang; Jim McNally; Joao Pedras-Vasconcelos; Renuka Pillutla; Joleen T White; Yuanxin Xu; Shalini Gupta
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

4.  MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.

Authors:  Kevin A O'Connor; Kathy A Abbott; Brad Sabin; Maxine Kuroda; Lauren M Pachman
Journal:  Clin Immunol       Date:  2006-07-21       Impact factor: 3.969

Review 5.  Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report.

Authors:  Hans-P Hartung; Chris Polman; Antonio Bertolotto; Florian Deisenhammer; Gavin Giovannoni; Eva Havrdova; Bernhard Hemmer; Jan Hillert; Ludwig Kappos; Bernd Kieseier; Joep Killestein; Christophe Malcus; Manuel Comabella; Andrew Pachner; Huub Schellekens; Finn Sellebjerg; Krysztof Selmaj; Per Soelberg Sorensen
Journal:  J Neurol       Date:  2007-04-24       Impact factor: 4.849

6.  A sensitive radioimmunoprecipitation assay for assessing the clinical relevance of antibodies to IFN beta.

Authors:  N Lawrence; J Oger; T Aziz; J Palace; A Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

7.  A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging.

Authors:  A W Chiu; M Ehrmantraut; N D Richert; V N Ikonomidou; S Pellegrini; H F McFarland; J A Frank; F Bagnato
Journal:  Clin Exp Immunol       Date:  2007-07-30       Impact factor: 4.330

8.  Use of a standardized MxA protein measurement-based assay for validation of assays for the assessment of neutralizing antibodies against interferon-β.

Authors:  Meenu Wadhwa; Meena Subramanyam; Susan Goelz; Jaya Goyal; Vijay Jethwa; Wendy Jones; James G Files; Daniel Kramer; Chris Bird; Paula Dilger; Michael Tovey; Christophe Lallemand; Robin Thorpe
Journal:  J Interferon Cytokine Res       Date:  2013-07-13       Impact factor: 2.607

9.  Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies.

Authors:  Hans-Peter Hartung; Bernd Kieseier; Douglas S Goodin; Barry Gw Arnason; Giancarlo Comi; Stuart Cook; Massimo Filippi; Douglas R Jeffery; Ludwig Kappos; Timon Bogumil; Brigitte Stemper; Rupert Sandbrink; Yukiko Nakada; Haruhiko Nakajima; Susanne Schwenke; Stephan Lehr; Jürgen Heubach; Christoph Pohl; Joachim Reischl
Journal:  J Neuroinflammation       Date:  2012-06-15       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.